Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
View original on the-decoder.comSummary
Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time from twelve years to seven or eight and double the success rate from 8 to 16 percent. The article Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable appeared first on The Decoder.
SpinGraph analysis pending — check back after processing.
Ask AI about this story
See how AI engines summarize this narrative — one click, prompt included.
More from The Decoder
View all →- A 26,000-student study shows AI's hidden learning cost takes two full years to surface
- OpenAI cofounder envisions "almost no interface" future where nobody learns software anymore
- Mistral's open-source Leanstral 1.5 aces formal math benchmarks and catches real bugs in code
- Microsoft follows Anthropic and OpenAI into the AI super app race with overhauled Copilot and AutoPilot agents
- Claude Code's complicated China problem involves bans on both sides of the Pacific
- UK's AI Security Institute finds standard benchmarks systematically underestimate what AI agents can actually do
Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO